Newsletter | September 20, 2023

09.20.23 -- ARPA-H NITRO: An Osteoarthritis Cure Rocket Fuel Or TNT?


Is Osteoarthritis Cure — ARPA-H NITRO — Rocket Fuel Or TNT?

The U.S. federal government just unveiled a moonshot to fix osteoarthritis. Rumored to be funded at $1 billion and launched out of the new Advanced Research Project Agency for Health (ARPA-H), the Novel Innovations for Tissue Regeneration in Osteoarthritis, or NITRO program, plans to cure OA in five years. But can it be done?

Rare Disease And Precision Medicine: A Road To Growth

As precision medicine advances, discover how the timing of rare disorder diagnosis could be improved so that treatment can begin at earlier stages of the illness.

FDA Covariate Adjustment Guide: What Nonstatisticians Should Know

Nonstatistical team members are encouraged to read this summary regarding the FDA’s guidance to better understand and support covariate adjustments applied in clinical trials.

Shorten The Path: From Discovery To Approval Of Novel Therapies

Unearth how Medidata Trial Design was able to utilize historical trial data and real-life examples across different indications throughout the clinical development process in five case studies.

Considerations For Clinical Trial Success

Advancing to clinical trials is an exciting milestone in drug development — but it can also be daunting. Arm your team with important factors to consider by exploring this infographic.

Advanced Imaging: Overcoming Challenges In Immuno-Oncology

Watch as speakers review immunotherapy, discuss a range of current and developing approaches, and explore the unique challenges that the new treatment options present in a clinical trial setting.

Signant SmartSignals RTSM: Trial Supply Management, Optimized

Embark on a journey to uncover six compelling reasons behind adopting this RTSM solution, which boasts a modern front-end interface, for your upcoming study.

Get Products Through Development, Commercialization, And Beyond

Speed solutions combine value-added services and expertise, delivering an integrated approach, de-risking the supply chain by eliminating the need to transfer to alternative suppliers.

Selecting The Right Pain Model For Your Early-Phase Analgesic Trials

With over 20 years of experience, Altasciences’ pain experts and neuroscientists are here to guide the most appropriate pain model selection for evaluating the efficacy and safety profile of your study drug.


Flexible Solutions Provide Critical Site Support

Across the pharmaceutical industry, clinical research sites face many challenges. Individual sites vary widely and need flexible, tailor-made solutions that can evolve and adapt to their unique needs.

How Mobile Nurses Positively Impact Social Determinants Of Health

Social determinants of health are among the reasons for low participation in clinical trials among minority communities. This is an area in which home research nurses can make a significant positive impact.


You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: